MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 87 filers reported holding MUSTANG BIO INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $34 | -96.6% | 85 | -93.8% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 1,369 | -50.4% | 0.00% | – |
Q2 2022 | $2,000 | -60.0% | 2,759 | -47.1% | 0.00% | – |
Q1 2022 | $5,000 | -86.5% | 5,214 | -76.3% | 0.00% | – |
Q4 2021 | $37,000 | +68.2% | 21,989 | +173.9% | 0.00% | – |
Q3 2021 | $22,000 | -67.2% | 8,029 | -60.4% | 0.00% | – |
Q2 2021 | $67,000 | +509.1% | 20,253 | +497.1% | 0.00% | – |
Q1 2021 | $11,000 | -69.4% | 3,392 | -64.3% | 0.00% | – |
Q4 2020 | $36,000 | +620.0% | 9,497 | +560.9% | 0.00% | – |
Q3 2020 | $5,000 | -58.3% | 1,437 | -62.6% | 0.00% | – |
Q2 2020 | $12,000 | -42.9% | 3,839 | -51.8% | 0.00% | – |
Q1 2020 | $21,000 | -12.5% | 7,962 | +33.9% | 0.00% | – |
Q4 2019 | $24,000 | +200.0% | 5,946 | +136.1% | 0.00% | – |
Q3 2019 | $8,000 | -72.4% | 2,518 | -67.7% | 0.00% | – |
Q2 2019 | $29,000 | +93.3% | 7,798 | +78.6% | 0.00% | – |
Q1 2019 | $15,000 | +25.0% | 4,366 | +2.8% | 0.00% | – |
Q4 2018 | $12,000 | -53.8% | 4,247 | -4.1% | 0.00% | – |
Q3 2018 | $26,000 | +30.0% | 4,430 | +55.7% | 0.00% | – |
Q2 2018 | $20,000 | – | 2,846 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
EMFO, LLC | 32,000 | $32,000 | 0.03% |
B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |